Working at Pfizer

Through the acquisition of Wyeth by Pfizer, I was fortunate to have the opportunity to take on a new role while also leading our remaining team in landing roles throughout the new Pfizer organization. I had the support of some key leaders in the Pfizer R&D team in landing most of my team, and I was able to take on the global lead role for our ELN platform, bringing the first in Pfizer GLP instance of an ELN over, complimenting the existing non-regulated platform that was in place.

From there, my scope of responsibility changed to include technology leadership for global R&D sites across the United States, Europe and Asia as well as the lead for the Acquisitions, Collaborations and Divestitures work across Pfizer Diversified Business (Non-Pharma) R&D. While in this role, I led the R&D portion of the acquisition of multiple companies and assimilation into the Pfizer family resulting in market growth and geographic expansion for our Consumer Health business.

I led a large combined business and technology team in the global rollouts and change management of our lab platforms, moving onto Electronic Lab Notebooks, replacing our LIMS and upgrading data acquisition and archiving solutions to enterprise systems resulting in a more standardized environment that facilitated our global collaboration and development, in support of our expansion and growth goals for our fast moving Consumer Health business.

After leaving the Research side, I worked with the Global Franchise teams representing our diverse portfolio of brands across the world, as well as our Innovation Alchemy organization, helping us bring innovation and freshness to our business. I was also responsible for our Global Product Portfolio Management organization, focused on tracking and managing our global development projects. My work with the portfolio expanded to include responsibility for our Data Analytics practice, collaborating with the Pfizer enterprise teams to develop and manage our global information and data strategies in Consumer Health R&D.

A number of my former Wyeth colleagues also made the transition to Pfizer, and you will see overlap in recommendations between the two organizations. I am grateful for the extensive investment Pfizer makes in its’ leaders, as I was able to take advantage of a great deal of fantastic training while working in these various roles, as well as the benefits of working with some great people.

What my colleagues have said about my work:

Jim is extremely customer focused and focuses on doing the right job, for the right reasons. He has the ability to work with the clients to develop their long-term strategy, and work to get the necessary buy-in of senior/top level management. Jim is extremely professional and is always pleasant to work with.

Adrienne Fischer
ASQ Six Sigma Greenbelt

Jim and I have worked together for a number of years. I have always been impressed with his thought leadership, especially in the area of Lab systems and R&D information systems. Jim is thorough, hard working, and develops strong collaborative relationships. A great senior leader who knows how to find bottom line efficiency while delivering advanced technological capabilities to R&D organizations.

Dennis Hancock
VP, Digital Solutions & Emerging Tech at Pfizer. Making an impact with advanced technology in healthcare. PACT Board

Jim’s business acumen and strategic visioning is second to none. To state he can develop, communicate, and execute on a 1, 3, 5, year strategy is an understatement.

I have had the pleasure of collaborating with Jim on life sciences projects specifically related to quality control systems (e.g. LIMS). Jim not only leads his teams to deliver the technology but mentors his teams in the value of business process knowledge for successful implementation.

I have witnessed Jim successfully address executive management and colleagues at Pfizer. Jim is adept at managing budgets and HR aspects which one would expect from a senior leader role. I would have no issue working under or in collaboration with Jim.

Mitchell Haber ITILv3, CSSGB, GMPCP
Regulatory Compliance and Oversight Lead, Worldwide Regulatory Operations at Pfizer

Jim has a rare ability to combine a commitment to making his project a success technically while keeping both internal clients and his suppliers on-side. Jim demanded a lot from me as a supplier and at the same time understood my constraints and as a result he achieved excellent results for Pfizer.

Phil Mahoney
CEO Ambition Partner Ltd
Ambition Partner Ltd

I have had the pleasure of working with Jim during his time at Wyeth as well as Pfizer most recently. What differs Jim most from others is his vision and ability to orchestrate change. He confidently represents his beliefs even when it goes against ‘business as usual’.

Jim takes a big picture approach combined with his considerable team building and leadership skills to effect powerful change for the business units he supports. Instead of focusing on needs more founded in a particular system or user group which are indicative of a more holistic business issue, Jim focuses on the data landscape and business process issues. In re-architecting the flow and availability of information and enhancing the overall lab operation, he addresses many of the lower-level issues while achieving more significant ROI.

Michael Hampton
VP North American Operations

Jim is strategic thinker that quickly understands the business issues and drivers. He is creative and consistently designed and implemented business technology solutions that simplified processes and made it easier for the business to get things done. Jim is results oriented and consistently implements projects on time and within budget.

Bill Keller
Finance Director, Pfizer Consumer Healthcare

Jim King is an industry Leader in Business Technology and Lab and Operations.

Jim is an innovative and strategic business leader who has a proven track record for delivering quantifiable and successful results in a corporate setting. Driven by results and critical thinking, Jim has always delivered within budget and on time, often exceeding expectations. As a dynamic speaker and an expert at relationship building, Jim has successfully demonstrated himself as a leader as well as a team player. He is a trustworthy friend and a dedicated, reliable colleague who consistently provided the team with objective, grounded and big-picture viewpoints.

Jim’s experience in trend setting and innovation in the areas of Lab Operations, Informatics and Business Operation have made him a respected and valuable industry leader. His breadth of knowledge, experience and leadership have been instrumental assets to the successes within the Pharma arena.

Christopher Stanco
Director at Pfizer, Consumer Healthcare, Global R&D - Richmond Business Technology Site Lead

I have worked with Jim for several years collaborating on the development and implementation of BT solutions for the Pfizer’s Consumer Healthcare Business. I quickly grew to appreciate Jim’s broad breadth of knowledge and his ability to link that to develop practical solutions that support the business. He is able to listen to what ‘the customer’ needs, develop the appropriate strategy and then implement it. His execution of projects is exemplary – he always delivers ! Always a great partner to collaborate with.

Rob Burrows, VP - Head of Pfizer Consumer Health Supply
Pfizer Consumer Health